Other Events ·
On June 9, 2026, Celularity Inc. received notice from Nasdaq that it failed to meet the minimum Market Value of Listed…
CELUCelularity Inc
On June 9, 2026, Celularity Inc. received notice from Nasdaq that it failed to meet the minimum Market Value of Listed Securities (MVLS) requirement of $35 million for 30 consecutive business days. The company has until December 7, 2026, to regain compliance by maintaining a market value of at least $35 million for 10 consecutive business days or by increasing stockholders' equity to at least $2.5 million. Failure to comply may result in delisting from the Nasdaq Capital Market. Celularity Inc. is a biotechnology company focused on developing cell therapies.